74%
of retail investor accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
74%
of retail investor accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
English (International)
Tactile Systems Technology Inc
Open
SectorHealthcare
28.42 -3.1
Overview
Share price change
24h
Min
28.19
Max
29.46
Income | 2.4M 11M |
|---|---|
Sales | 18M 104M |
P/E Sector Avg | 35.72 66.845 |
EPS | 0.46 |
Profit margin | 10.265 |
Employees | 1,086 |
EBITDA | 7.3M 20M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +25.95% upside |
Next Earnings | 4 May 2026 |
|---|
Market Cap | 66M 657M |
|---|---|
Previous open | 31.52 |
Previous close | 28.42 |
News Sentiment
By Acuity
50%
50%
168 / 351 Healthcare
Technical Score
By Trading Central
Confidence
Very Strong Bearish Evidence
Tactile Systems Technology Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Tactile Systems Technology Inc Forecast
Price Target
By TipRanks
25.95% upside
12 Months Forecast
Average 38 USD 25.95%
High 42 USD
Low 32 USD
Based on 5 Wall Street analysts offering 12 month price targets forTactile Systems Technology Inc - Dist in the last 3 months.
Sentiment
By Acuity
168 / 351 Healthcare
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Tactile Systems Technology Inc
Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company also provides Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.
Live chat